lebrikizumab

Italy

Drugs containing this active substance

  • EBGLYSS

    It is used for the treatment of adults and adolescents (from 12 years of age and weighing at least 40 kg) suffering from moderate to severe atopic dermatitis, also known as atopic eczema.

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    lebrikizumab -

    ATC: D11AH

    Manufacturer: ALMIRALL S.A.